Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Import Bill Could Be Modeled On Food Inspection Program – McClellan

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner highlights Congress' 2002 law enhancing FDA's and USDA's authority and resources for inspecting imported foods during testimony before Senate Commerce Committee.

You may also be interested in...



HHS Secretary Nominee Leavitt Could Increase Focus On Medicaid Reform

President Bush nominates EPA Administrator Mike Leavitt to succeed Tommy Thompson as HHS secretary. Leavitt gained attention for his Medicaid reform initiatives during his time as Utah governor and helped develop the Bush Administration's 2003 Medicaid proposal.

HHS Secretary Nominee Leavitt Could Increase Focus On Medicaid Reform

President Bush nominates EPA Administrator Mike Leavitt to succeed Tommy Thompson as HHS secretary. Leavitt gained attention for his Medicaid reform initiatives during his time as Utah governor and helped develop the Bush Administration's 2003 Medicaid proposal.

Drug Importation Debate Highlights Need For Lower Rx Prices - CMS Administrator

The findings of the HHS importation task force and the new Medicare drug benefit will lead to lower prices for consumers, CMS Administrator McClellan tells NACDS. Fairer international pricing, including reduced prices of generics in other countries, is also a way forward, he adds.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel